New Report Available: Global Biopolar Disorder Therapeutics Market 2015-2019

From: Fast Market Research, Inc.
Published: Sun Jan 10 2016

Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in for treatment. It is considered as a lifelong disease and the discontinuation of the medication can lead to relapse of the condition.

Technavio's analysts forecast the global bipolar disorder therapeutics market to grow at a CAGR of 2.24% over the period 2014-2019.

Covered in this report

The report covers the present scenario and growth prospects of the global bipolar disorder therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of bipolar disorder.

Full Report Details at

Technavio's report, Global Bipolar Disorder Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global bipolar disorder therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

* Americas

Key vendors

* Allergan
* AstraZeneca
* Eli Lilly
* GlaxoSmithKline
* Janssen Pharmaceuticals

Other prominent vendors

* AbbVie
* Abital Pharma
* Astellas
* Convergence Pharmaceuticals
* D Pharm
* Delpor
* Gedeon Richter
* H. Lundbeck
* Intra-Cellular Therapies
* Novartis
* Noven Pharmaceuticals
* Omeros Corporation
* Otsuka
* Pfizer
* PNBDevCo
* Reviva Pharmaceuticals
* SK Biopharmaceuticals
* Sunovion Pharmaceutical

Key market driver

* Increase in prevalence of bipolar disorder
* For a full, detailed list, view our report

Key market challenge

* Use of alternative therapies
* For a full, detailed list, view our report

Key market trend

* Rise in public awareness
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2019 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019
- Global Opthalmic Therapeutic Market 2015-2019
- Glomerulonephritis Global Clinical Trials Review, H2, 2015
- Cancer Pain Global Clinical Trials Review, H1, 2015
- Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »